The trial, called CALAVI, will assess the effect of Calquence on the exaggerated immune response of patients hospitalised with COVID-19…
European Commission approves Sandoz Rixathon® to treat blood cancers and immunological diseases. Approval expected to broaden patient access to biologics…
NEWCASTLE, 9-6-2015 — /EuropaWire/ — A world-renowned blood cancers expert has been given a prestigious award in recognition of his…
LEEDS, 20-5-2014 — /EuropaWire/ — A pioneering database at the University of Leeds will help match patients with certain types of…